Table 3. Individual Subject Outcomes.
Subject | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
---|---|---|---|---|---|---|---|---|---|
FEV1 (% predicted) at 3 months27 | 44 | Unable to perform | 25 | 38 | 32 | 36 | 42 | 21 | 43 |
FEV1 (% predicted) at 12 months27 | 66 | 62 | 43 | 65 | 65 | 70 | 34 | 38 | N/A |
Best FEV1 (% predicted) any time in the first 12 months27 | 69 | 63 | 43 | 65 | 65 | 70 | 54 | 53 | 43 |
Walk distance at discharge, m | 183 | ND | 457 | 213 | 366 | 549 | 91 | 1,067 | 1,829 |
Total ICU stay, d | 39 | 49 | 60 | 48 | 23 | 25 | 33 | 22 | 30 |
Total hospital stay, d | 51 | 102 | 86 | 151 | 53 | 50 | 63 | 31 | 47 |
Status at data collection | Alive at 65 months | Died at 50 months | Alive at 54 months | Alive at 47 months | Died at 16 months | Alive at 25 months | Alive at 23 months | Died at 17 months | Alive at 4 months |
ND = no data available